Data / Drug companies / Homosalate, octisalate, zinc oxide
Homosalate, octisalate, zinc oxide: 11 companies and 92 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Homosalate, octisalate, zinc oxide is listed in the FDA National Drug Code Directory by 11 companies, with 92 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; liquid; solution/ drops, and the newest product started marketing on August 24, 2026.
The request: Get every company that lists homosalate, octisalate, zinc oxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 11
- Products
- 92
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- Buildable Blur, ProtecTINT 14N, ProtecTINT 46N, Perfecting Blendrops Broad Spectrum SPF 46, ProtecTINT 26W, ProtecTINT 34C, ProtecTINT 30W, ProtecTINT 42C
- openFDA record search
- api.fda.gov
Companies that list homosalate, octisalate, zinc oxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cosmax USA, Corporation | 28 | cream | Over the counter monograph drugs | December 1, 2022 |
| Distribuidora Comercial Jafra, S.A. de C.V. | 19 | liquid | Over the counter monograph drugs | March 1, 2025 |
| PML Nyc, LLC | 14 | cream | Over the counter monograph drugs | November 22, 2023 |
| Supergoop, LLC | 14 | cream | Over the counter monograph drugs | November 22, 2023 |
| Wasatch Product Development, LLC | 9 | solution/ drops | Over the counter monograph drugs | October 20, 2025 |
| Obagi Cosmeceuticals LLC | 3 | kit | Other unapproved drugs | December 2, 2019 |
| Aldi, Inc | 1 | lotion | Over the counter monograph drugs | August 24, 2026 |
| Cosnova GmbH | 1 | stick | Over the counter monograph drugs | January 1, 2025 |
| Skinplan.us LLC | 1 | cream | Over the counter monograph drugs | April 22, 2024 |
| The Seaweed Bath Co. | 1 | liquid | Over the counter monograph drugs | January 3, 2022 |
| Topco Associates LLC | 1 | lotion | Over the counter monograph drugs | January 22, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 57 | 62% |
| Liquid | 20 | 21.7% |
| Solution/ drops | 9 | 9.8% |
| Kit | 3 | 3.3% |
| Lotion | 2 | 2.2% |
| Stick | 1 | 1.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 89 | 96.7% |
| Other unapproved drugs | 3 | 3.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 2 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.